MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 6.30
-0.10 (-1.56%)
Apr 2, 2025, 4:11 PM CET
MaaT Pharma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | - | 24.28 | 35.25 | 43.31 | 19.91 | Upgrade
|
| Short-Term Investments | - | 0.03 | 0.06 | - | - | Upgrade
|
| Cash & Short-Term Investments | - | 24.31 | 35.31 | 43.31 | 19.91 | Upgrade
|
| Cash Growth | - | -31.14% | -18.46% | 117.47% | 268.01% | Upgrade
|
| Accounts Receivable | - | 5.16 | 4.24 | 2.39 | 1.65 | Upgrade
|
| Other Receivables | - | 1.04 | 0.78 | 0.98 | 0.59 | Upgrade
|
| Receivables | - | 6.21 | 5.02 | 3.37 | 2.24 | Upgrade
|
| Inventory | - | 0.19 | 0.05 | 0.03 | - | Upgrade
|
| Prepaid Expenses | - | 1.13 | 1.58 | 0.43 | 0.04 | Upgrade
|
| Other Current Assets | - | 0.15 | 0.16 | 0.13 | 0 | Upgrade
|
| Total Current Assets | - | 31.99 | 42.12 | 47.27 | 22.19 | Upgrade
|
| Property, Plant & Equipment | - | 9.17 | 0.97 | 1.11 | 1.1 | Upgrade
|
| Long-Term Investments | - | 0.2 | 0.3 | 0.1 | 0.1 | Upgrade
|
| Other Intangible Assets | - | 1.34 | 1.2 | 0.81 | 0.75 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | -0 | Upgrade
|
| Total Assets | - | 42.93 | 44.73 | 49.42 | 24.28 | Upgrade
|
| Accounts Payable | - | 6.35 | 4.51 | 2.47 | 1.4 | Upgrade
|
| Accrued Expenses | - | 1.29 | 1.24 | 0.69 | 0.49 | Upgrade
|
| Current Portion of Long-Term Debt | - | 2.22 | 2.77 | 1.06 | 0.78 | Upgrade
|
| Current Portion of Leases | - | 1.23 | 0.21 | 0.19 | 0.08 | Upgrade
|
| Current Income Taxes Payable | - | 0.06 | 0.05 | 0.03 | 0.03 | Upgrade
|
| Other Current Liabilities | - | 0.37 | 0.44 | 0.25 | 0.07 | Upgrade
|
| Total Current Liabilities | - | 11.52 | 9.22 | 4.7 | 2.86 | Upgrade
|
| Long-Term Debt | - | 5.75 | 7.94 | 3.98 | 4.72 | Upgrade
|
| Long-Term Leases | - | 4.87 | 0.43 | 0.57 | 0.49 | Upgrade
|
| Other Long-Term Liabilities | - | 0.15 | 0.23 | 0.19 | 0.19 | Upgrade
|
| Total Liabilities | - | 22.47 | 17.92 | 9.56 | 8.34 | Upgrade
|
| Common Stock | - | 1.16 | 0.99 | 0.99 | 0.66 | Upgrade
|
| Additional Paid-In Capital | - | 37.38 | 38.32 | 46.46 | 19.91 | Upgrade
|
| Retained Earnings | - | -17.86 | -12.37 | -7.6 | -4.63 | Upgrade
|
| Treasury Stock | - | -0.22 | -0.14 | - | - | Upgrade
|
| Shareholders' Equity | - | 20.47 | 26.81 | 39.86 | 15.94 | Upgrade
|
| Total Liabilities & Equity | - | 42.93 | 44.73 | 49.42 | 24.28 | Upgrade
|
| Total Debt | - | 14.08 | 11.36 | 5.81 | 6.08 | Upgrade
|
| Net Cash (Debt) | - | 10.24 | 23.95 | 37.5 | 13.84 | Upgrade
|
| Net Cash Growth | - | -57.25% | -36.13% | 171.00% | - | Upgrade
|
| Net Cash Per Share | - | 0.90 | 2.42 | 15.45 | 13.40 | Upgrade
|
| Filing Date Shares Outstanding | - | 11.6 | 11.54 | 9.89 | 1.03 | Upgrade
|
| Total Common Shares Outstanding | - | 11.59 | 9.94 | 9.88 | 1.03 | Upgrade
|
| Working Capital | - | 20.47 | 32.91 | 42.57 | 19.33 | Upgrade
|
| Book Value Per Share | - | 1.77 | 2.70 | 4.03 | 15.44 | Upgrade
|
| Tangible Book Value | - | 19.12 | 25.61 | 39.05 | 15.19 | Upgrade
|
| Tangible Book Value Per Share | - | 1.65 | 2.58 | 3.95 | 14.71 | Upgrade
|
| Machinery | - | 1.25 | 0.99 | 0.73 | 0.65 | Upgrade
|
| Construction In Progress | - | 0.52 | 0.07 | - | 0.12 | Upgrade
|
Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.